These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27170663)

  • 21. Preeclampsia is associated with the presence of transcriptionally active placental fragments in the maternal lung.
    Buurma AJ; Penning ME; Prins F; Schutte JM; Bruijn JA; Wilhelmus S; Rajakumar A; Bloemenkamp KW; Karumanchi SA; Baelde HJ
    Hypertension; 2013 Sep; 62(3):608-13. PubMed ID: 23817495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
    Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
    Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of pravastatin on the normal human placenta: Lessons from ex-vivo models.
    Balan A; Szaingurten-Solodkin I; Swissa SS; Feinshtein V; Huleihel M; Holcberg G; Dukler D; Beharier O
    PLoS One; 2017; 12(2):e0172174. PubMed ID: 28199380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model.
    Kumasawa K; Ikawa M; Kidoya H; Hasuwa H; Saito-Fujita T; Morioka Y; Takakura N; Kimura T; Okabe M
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1451-5. PubMed ID: 21187414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of complement component C1q in the onset of preeclampsia in mice.
    Singh J; Ahmed A; Girardi G
    Hypertension; 2011 Oct; 58(4):716-24. PubMed ID: 21859968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular hydrogen ameliorates several characteristics of preeclampsia in the Reduced Uterine Perfusion Pressure (RUPP) rat model.
    Ushida T; Kotani T; Tsuda H; Imai K; Nakano T; Hirako S; Ito Y; Li H; Mano Y; Wang J; Miki R; Yamamoto E; Iwase A; Bando YK; Hirayama M; Ohno K; Toyokuni S; Kikkawa F
    Free Radic Biol Med; 2016 Dec; 101():524-533. PubMed ID: 27789293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy.
    Gurnadi JI; Mose J; Handono B; Satari MH; Anwar AD; Fauziah PN; Yogi Pramatirta A; Rihibiha DD
    BMC Res Notes; 2015 Oct; 8():534. PubMed ID: 26434493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
    Xu B; Thornton C; Tooher J; Ogle R; Lim S; Makris A; Hennessy A
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression and significance of soluble fms-like tyrosine kinase 1 in preeclampsia placenta].
    Ye YH; Liu L; Zhan Y; Peng W
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):521-4. PubMed ID: 17083834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of hypoxia-inducible factor-1alpha, vascular endothelial growth factor and sFlt-1 in preeclampsia placenta].
    Sun SG; Shen N; Zheng YH; Shang T
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):440-4. PubMed ID: 17083805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human umbilical cord mesenchymal stem cell derived exosomes (HUCMSC-exos) recovery soluble fms-like tyrosine kinase-1 (sFlt-1)-induced endothelial dysfunction in preeclampsia.
    Chang X; He Q; Wei M; Jia L; Wei Y; Bian Y; Duan T; Wang K
    Eur J Med Res; 2023 Aug; 28(1):277. PubMed ID: 37559150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy.
    Szalai G; Xu Y; Romero R; Chaiworapongsa T; Xu Z; Chiang PJ; Ahn H; Sundell B; Plazyo O; Jiang Y; Olive M; Wang B; Jacques SM; Qureshi F; Tarca AL; Erez O; Dong Z; Papp Z; Hassan SS; Hernandez-Andrade E; Than NG
    PLoS One; 2014; 9(11):e110867. PubMed ID: 25393290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice.
    Suzuki H; Ohkuchi A; Matsubara S; Takei Y; Murakami M; Shibuya M; Suzuki M; Sato Y
    Hypertension; 2009 Nov; 54(5):1129-35. PubMed ID: 19786649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased interaction between heat shock protein 27 and mitogen-activated protein kinase (p38 and extracellular signal-regulated kinase) in pre-eclamptic placentas.
    Shin JK; Jeong YT; Jo HC; Kang MY; Chang IS; Baek JC; Park JK; Lee SA; Lee JH; Choi WS; Paik WY
    J Obstet Gynaecol Res; 2009 Oct; 35(5):888-94. PubMed ID: 20149037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pravastatin for early-onset pre-eclampsia: a randomised, blinded, placebo-controlled trial.
    Ahmed A; Williams DJ; Cheed V; Middleton LJ; Ahmad S; Wang K; Vince AT; Hewett P; Spencer K; Khan KS; Daniels JP;
    BJOG; 2020 Mar; 127(4):478-488. PubMed ID: 31715077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice.
    Szalai G; Romero R; Chaiworapongsa T; Xu Y; Wang B; Ahn H; Xu Z; Chiang PJ; Sundell B; Wang R; Jiang Y; Plazyo O; Olive M; Tarca AL; Dong Z; Qureshi F; Papp Z; Hassan SS; Hernandez-Andrade E; Than NG
    PLoS One; 2015; 10(4):e0119547. PubMed ID: 25860260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear factor of activated T-cells (NFAT) regulates soluble fms-like tyrosine kinase-1 secretion (sFlt-1) from human placenta.
    Ye L; Gratton A; Hannan NJ; Cannon P; Deo M; Palmer KR; Tong S; Kaitu'u-Lino TJ; Brownfoot FC
    Placenta; 2016 Dec; 48():110-118. PubMed ID: 27871461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gadd45α as an upstream signaling molecule of p38 MAPK triggers oxidative stress-induced sFlt-1 and sEng upregulation in preeclampsia.
    Luo X; Yao ZW; Qi HB; Liu DD; Chen GQ; Huang S; Li QS
    Cell Tissue Res; 2011 Jun; 344(3):551-65. PubMed ID: 21519896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.
    Shibata E; Rajakumar A; Powers RW; Larkin RW; Gilmour C; Bodnar LM; Crombleholme WR; Ness RB; Roberts JM; Hubel CA
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4895-903. PubMed ID: 15886253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simvastatin Alleviates Pathology in a Rat Model of Preeclampsia Involving ERK/MAPK Pathway.
    Dong X; Shi D
    Reprod Sci; 2017 Jul; 24(7):1053-1061. PubMed ID: 27856999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.